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ABSTRACT 
Recent research has shown the possibility of pain perception in fish; therefore, the use of analgesia or 
“painkillers” should be considered for invasive procedures. However, there is relatively little information on 
the effectiveness of analgesic drugs nor on the appropriate dose for fish. This study assessed the efficacy 
of three types of drug: an opioid, buprenorphine, a non-steroidal anti-inflammatory drug (NSAID), 
carprofen and a local anaesthetic, lidocaine. Each drug was tested at three doses on rainbow trout that 
were noxiously stimulated and the most effective dose was also given to fish experiencing no pain to 
investigate side-effects. Ventilation rate and time to resume feeding were used as pain indicators, 
together with the amount of activity and plasma cortisol concentrations to gauge any detrimental side 
effects. Buprenorphine at all three doses had limited impact on the fish’s response to a painful stimulus. 
Carprofen ameliorated effects of noxious stimulation on time to resume feeding but activity was reduced 
more than by noxious treatment alone. Lidocaine reduced all of the pain indicators measured with the 
lowest, most effective dose being 1 mg per fish. None of the analgesics led to raised plasma cortisol 
compared to control groups. This study demonstrates that lidocaine could be recommended for use in 




Analgesics are administered in veterinary practice to alleviate pain in mammals, birds and reptiles (Fowler 
and Miller, 2003; Rang et al., 2007). They should be used preceding or following potentially painful 
surgical procedures and to reduce pain associated with chronic disease (Fowler and Miller, 2003). 
Despite the use of analgesia in other species, fish undergoing invasive procedures are generally not 
administered analgesia (Harms et al., 2005). The debate as to whether fish have the capacity to perceive 
pain has intensified since nociceptors that detect painful stimuli were identified in the rainbow trout, 
Oncorhynchus mykiss (Rose, 2002; Sneddon, 2002, 2004, 2009; Iwama, 2007). However, all authors 
agree that improving fish welfare is important regardless of whether they agree upon the question of fish 
experiencing pain (Rose, 2002; Iwama, 2007). If analgesics are shown to ameliorate adverse responses 
to a painful event, then their use should be recommended. A limited number of studies have investigated 
the effects of analgesics in fish, including morphine, butorphanol and ketoprofen (Sneddon, 2003a; 
Sneddon et al., 2003; Harms et al., 2005; Davis et al., 2006; Newby et al., 2006, 2007; Nordgreen et al., 
2009). However, these drugs have been tested mainly in isolation and on individual species of fish. 
Recent studies have not only demonstrated nociception in a teleost fish (Sneddon, 2002; Sneddon, 
2003b; Ashley et al., 2006, 2007), but have also shown that fish display adverse behaviours following a 
noxious event, suggestive of pain and discomfort (Sneddon, 2003a; Reilly et al., 2008a; Ashley et al., 
2009). These behavioural responses are reduced by morphine, an opioid analgesic, in rainbow trout 
(Sneddon, 2003a; Sneddon et al., 2003). Both ketoprofen, a non-steroidal anti-inflammatory drug 
(NSAID), and butorphanol, an opioid drug, have been used but of these two, only butorphanol was 
effective in reducing changes in post-surgical activity patterns in Koi carp, Cyprinus carpio (Harms et al., 
2005) and neither were effective in reducing minimum anaesthetic concentrations in the chain dogfish, 
Scyliorhinus retifer (Davis et al., 2006), demonstrating the difficulty of extrapolating findings between 
species. 
Some invasive procedures that are carried out routinely in aquaculture, fisheries and scientific 
experimentation, such as tagging and vaccination, could potentially be painful if they involve tissue 
damage (Hastein et al., 2005). In addition, veterinarians are increasingly asked to perform surgery on 
valuable, large ornamental fish, and it is possible that analgesic use could enhance the success of such 
interventions (Harms et al., 2005). Thus, determining analgesic protocols for use during invasive 
procedures could be of direct practical benefit by promoting recovery and increasing wellbeing. In 
addition, “modification of response to noxious stimuli by analgesics” is one of the eight criteria that an 
animal must fulfil to substantiate its capacity to perceive pain (Bateson, 1991). As there is still debate 
regarding whether fish are capable of conscious awareness of pain or merely demonstrate reflex 
reactions to noxious stimuli, a more thorough evaluation of whether or not analgesics affect a fish’s 
response to a potentially painful event will provide constructive evidence for this discussion. 
The aim of the present study was to assess the efficacy of three analgesics: an opiate (buprenorphine), 
an NSAID (carprofen) and a local anaesthetic (lidocaine). These agents were chosen because they are 
frequently used in other species, are readily available and represent the three major analgesic groups, 
thus covering a range of analgesic mechanisms. Three doses were tested for each drug; these were 
determined by extrapolation of dosage data from other species (humans and those animals routinely 
seen in veterinary practice). We tested the hypothesis that each drug would produce analgesia thereby 
reducing the responses to noxious and potentially painful stimulation. We expected that they would work 
in a dose dependent fashion with higher doses producing more pronounced analgesia. Rainbow trout 
were chosen as subjects owing to their commercial importance and because they are a validated model 
with the capacity for nociception and pain (Sneddon, 2002, 2003a, 2003b; Sneddon et al., 2003; Dunlop 
and Laming, 2005; Dunlop et al., 2006; Ashley et al., 2007, 2009; Newby and Stevens, 2008; Reilly et al., 
2008a, 2008b). Subcutaneous injection of acetic acid was chosen as the noxious stimulus since this 
produces a prolonged behavioural and physiological response over 3 to 6 h in rainbow trout, that is 
reduced by administration of morphine (Sneddon, 2003a; Sneddon et al., 2003; Reilly et al., 2008a; 
Ashley et al., 2009). Previous studies have shown that these fish demonstrate significant changes in 
various behaviours (e.g. reduced swimming and activity, suspension of feeding, anomalous behaviours) 
and ventilation rate (indicator of stress) when exposed to a noxious stimulus (Sneddon, 2003a; Sneddon 
et al., 2003; Harms et al., 2005; Reilly et al., 2008a; Ashley et al., 2009). To determine drug efficacy and 
to identify possibly side-effects, we chose to monitor activity, time to resume feeding after treatment, 
ventilation rate and plasma cortisol concentration. Cortisol is used as an indicator of stress in fish as it is 
released during the primary stress response through activation of the hypothalamo-pituitary-interrenal 
(HPI) axis (Wendelaar Bonga, 1997). Similarly, in higher vertebrates glucocorticoid concentrations are 
commonly measured as indirect indicators during pain assessment (Rutherford, 2002). We expected that 
all indicators of pain, including the incidence of anomalous behaviours, increased ventilation rate and 
stress hormones, would be reduced with the use of analgesia.  
2. Materials and methods  
Experiments were carried out at the University of Liverpool using approved methods, working under 
provision of the Animals (Scientific Procedures) Act 1986, licensed by the Home Office, and following 
local ethics approval.  
2.1. Subjects and husbandry 
Female rainbow trout (mean size 111.2 g ± 49.1 g) were obtained from a commercial supplier (UK), and 
transferred to the aquarium in Liverpool. The use of females removed any confounding effects of gender 
on the study. Fish were housed in a stock tank (2 m x 2 m x 0.5 m; n = 120 fish per tank max), under a 
12:12 h light:dark regime. This semiclosed system was maintained with a constant flow of filtered fresh 
water at 12 ± 1 ◦C, and aeration provided via airline and an air stone linked to a compressed air supply. 
Fish were fed with a commercial trout feed (Skretting, Northwich, UK) at 1% bodyweight per day.  
After the fish had been allowed at least two weeks to recover from the stress of transport, they were 
carefully netted at random from the stock tank and transferred to individual glass observation tanks (45 
cm x 25 cm x 35 cm). One half of each tank was covered by dark, opaque material on the side, back and 
half of the top of the tank to provide a covered area for sheltering and to visually isolate the tanks. Each 
tank was provided with a gravel substrate, and a length of grey plastic pipe (approximately 15 cm long; 14 
cm diameter) in the covered area as a refuge. The semi-closed system was maintained with a constant 
flow of aerated filtered fresh water at 12 ± 1 ◦C, under a 12:12 h light:dark regime. The whole tank system 
was surrounded by a black curtain containing small observation holes, positioned  0.5 m from the tanks to 
prevent visual disturbance. Fish were fed commercial pellets, via a purpose-built dispenser, dropped at 
the same point in the uncovered tank area daily. In order to ensure that the fish were settled in the new 
environment experiments were only performed once a fish had been feeding consistently for at least three 
consecutive days. 
2.2. Treatment groups 
Three analgesics were tested: lidocaine (Sigma–Aldrich Co., UK), carprofen (“Rimadyl” Small Animal 
Solution for Injection, Pfizer Ltd., UK) and buprenorphine (“Temgesic”, Schering-Plough, UK). Doses were 
determined by extrapolation of dosage data from other species (Fowler and Miller, 2003; Tennant, 2005). 
Fish were assigned to one of 14 treatment groups (Table 1; n = 5 for each group; n = 70 total): a control 
group given saline, which is non-noxious as demonstrated by previous studies which showed handled fish 
with no injection were identical in their responses to saline injected fish (Sneddon, 2003a; Sneddon et al., 
2003); one group given acetic acid as a painful stimulus; nine groups given a combination of one 
analgesic at one of the three doses and acetic acid; and three further control groups given an analgesic 
alone at the most effective dose. The analgesic control group experiments were conducted at the end of 
the trials so that the dose used in the control groups could be determined according to which of the three 
trial doses appeared to be the most effective for each analgesic; this approach reduced the total number 
of animals used.  
Fish were caught by netting, anaesthetised by immersion in benzocaine dosed water (0.033 g l−1, the 
benzocaine having first been dissolved in ethanol at 0.033 g l−1; Sigma–Aldrich Co., UK), and weighed to 
the nearest 0.1 g. Sub-cutaneous (s.c.) injections (of 0.1 ml lidocaine and/or 0.1 ml of 0.1% acetic acid or 
0.1 ml saline) were administered using a sterile 1 ml syringe and needle (25 g), half into the upper frontal 
lip and half into the lower frontal lip. Lidocaine is a local anaesthetic and so we injected this into the same 
site as the acid, the frontal lips. For systemic analgesia, intramuscular (i.m.) injections of buprenorphine, 
carprofen or saline were injected into the muscle approximately 0.5 cm ventral to the dorsal fin on the left 
hand side using a sterile 1 ml syringe and needle (25 g). The saline was used to control for any adverse 
responses to the intramuscular injection.  
 
Table 1. Treatment groups designed to assess the effectiveness of the analgesics buprenorphine (B), carprofen (C) 
and lidocaine (L) in rainbow trout. Fish were assigned to one of 14 treatment groups (n = 5 for each group): saline 
control group (S), noxious acetic acid group (A), one of three analgesics (administered at three separate doses) plus 
acetic acid groups (BA, CA, LA), or to an analgesic and saline control group (BS, CS, LS). s.c. = subcutaneous 
injection of 0.1 ml of each agent administered half into the upper and half into the lower frontal lips; i.m. = 
intramuscular injection into the muscle ventral to the dorsal fin. The concentration of acetic acid was 0.1% and sterile 
saline was 0.9% NaCl. 
Group name Substances administered 
 s.c. i.m. 
S Saline Saline 
A Acid Saline 
0.01BA Acid Buprenorphine (0.01 mg kg−1) 
0.05BA Acid Buprenorphine (0.05 mg kg−1) 
0.10BA Acid Buprenorphine (0.10 mg kg−1) 
0.01BS Saline Buprenorphine (0.01 mg kg−1) 
1.0CA Acid Carprofen (1.0 mg kg−1) 
2.5CA Acid Carprofen (2.5 mg kg−1) 
5.0CA Acid Carprofen (5.0 mg kg−1) 
5.0CS Saline Carprofen (5.0 mg kg−1) 
0.5LA Acid and lidocaine (0.5 mg/fish) --- 
1.0LA Acid and lidocaine (1.0 mg/fish) --- 
2.0LA Acid and lidocaine (2.0 mg/fish) --- 
1.0LS Saline and lidocaine (1.0 mg/fish) --- 
 
 
2.3. Data collection 
Fish were filmed over the entire experiment using low light level video cameras, which were set up behind 
the curtain at least 1 h prior to recording to allow the fish to habituate to their presence. Fish behaviour 
was recorded onto VHS tape and then scored blind using the Hindsight programme (Hindsight for MS-
DOS, Ethological Recording and Analysis Software 1993–1996, Scott Weiss). 
Prior to treatment, the duration of activity (time (s) excluding being motionless or making small 
movements less than 1 cm measured using externally placed rulers vertically and horizontally (0.5 cm 
increments) at the front of the tank) and ventilation rate (operculum beats/min) of each fish were recorded 
for 15 min to obtain baseline data (pre-treatment behaviour and ventilation) with which to compare post-
treatment levels. Fish were then randomly assigned to one of the treatment groups. Each fish was 
injected individually, allowed 30 min to recover, and then offered 4 food pellets via the dispenser to see if 
it resumed feeding and ingested a pellet (this was done from behind the surrounding curtain to limit any 
visual disturbance). Ventilation rate and activity were then recorded as for pretreatment. Observations 
were repeated every 30 min for 3 h since it is known that the effects of a 0.1% acetic acid injection persist 
for up to 3 h (Sneddon, 2003a; Sneddon et al., 2003). At the end of the experiment, fish were euthanized 
using a Schedule 1 method (concussion followed by exsanguination), and a blood sample taken from the 
caudal vein (using a sterile heparinised 25 g needle and 2 ml syringe) for plasma cortisol analysis (carried 
out blind at an independent laboratory using a validated radioimmunoassay; Pottinger and Carrick, 2001). 
Experiments were carried out at the same time each day (commencing at 12 pm GMT), to minimise any 
effect of diurnal fluctuation in the plasma cortisol of the fish (Wendelaar Bonga, 1997). 
The data were either not normally distributed or non-parametric; therefore, non-parametric tests were 
employed. To determine the effects of acid (A) on trout behaviour and physiology Mann–Whitney U tests 
were used to identify any differences in ventilation rate and recovery rate, duration of activity, at 30 and 
180 min, and plasma cortisol concentrations compared with saline injected fish (S) and Wilcoxon signed 
rank tests were used to compare pre-treatment values with 30 and 180 min post treatment values with S 
and A groups. Ventilation rate of recovery per minute was calculated, from 30 min to 180 min after the 
treatment for each group giving one value per fish. Chi-squared goodness of fit tests with Yate’s 
correction were used to determine if treatment affected the time to resume feeding since these were 
categorical data. To analyse the efficacy of each analgesic and determine the most effective dose, they 
were compared with the saline group since the most effective analgesic should not differ from the saline 
injected fish. The time points of 30 and 180 min after treatment were chosen for analysis, as 30 min 
reflects the most intense effects of the treatment and the 180 min data indicate recovery, as observed in 
previous studies on rainbow trout (Fig. 2A; Sneddon, 2003a). Ventilation rates of recovery were analysed 
with Kruskal–Wallis tests to determine any differences between each of the groups within an analgesic 
compared with saline controls, and, where appropriate, post hoc Mann–Whitney U comparisons were 
made to compare each of the treatment groups to the S control group. Cortisol data were analysed using 
Kruskal–Wallis tests to determine any differences in plasma concentration between all groups. The 
amount of time spent active was analysed for differences between the analgesic groups and S controls 
using Kruskal–Wallis tests. Wilcoxon signed rank tests were used to compare each treatment group to its 
pre-treatment level at 30 and 180 min. Chi squared goodness of fit test was used to determine the effects 
of each analgesic dose on the time to resume feeding. 
Differences between the three analgesics were assessed by comparing the analgesic plus acid groups at 
the doses considered most effective for each analgesic with the saline group (4 groups in all). Ventilation 
rates (30 and 180 min), rates of recovery of ventilation, plasma cortisol, and time spent active (30 and 
180 min) after treatment were analysed using Kruskal–Wallis tests and, where appropriate, post hoc 
Mann–Whitney U comparisons. All statistics were calculated using two-tailed tests throughout with 
correction factors used where appropriate, using SPSS Version 14 or Version 15. 
 
Fig. 1. The median percentage (±IQR) change in activity from pretreatment (baseline) values at (A) 30 min and (B) 
180 min after rainbow trout were injected with saline, acid, buprenorphine and acid (BA), carprofen and acid (CA), 
lidocaine and acid (LA) or one of the three analgesics and saline (BS, CS, LS). Dose of analgesic is given (mg kg−1 or 
per fish) next to the appropriate label (a = P < 0.05 compared with pre-treatment activity using Wilcoxon analysis; b = 




3.1. Effects of acid alone 
Differences in ventilation rate, activity and time to resume feeding were observed between fish injected 
with saline (S) and those treated with acetic acid (A). Fish in the A group had significantly higher 
ventilation rates (Fig. 2A; U = 2.193, P = 0.028) than those in the S group. Group A fish also exhibited a 
longer latency to resume feeding (P = 0.001; Table 2). In addition, reduced activity compared to 
pretreatment was shown in group A fish (W = −2.50, P = 0.01), but not in group S fish. There were no 
significant differences between the S and A groups in the plasma cortisol concentrations at the end of the 
experiment (U = 0.522, P = 0.602).  
3.2. Effects of analgesics on behaviour 
3.2.1. Time to resume feeding 
Fish in the S group all resumed feeding by the 30 min time point whereas the other treatment groups took 
variable times to resume feeding (Table 2). None of the buprenorphine doses had a positive effect on the 
resumption of feeding. However, carprofen and lidocaine treated fish resumed feeding at similar times to 
the saline controls, except those fish given the lowest doses (1.0CA and 0.5LA), which took longer to 
resume feeding (Table 2).  
3.2.2. Duration of activity  
There was a difference in the duration of activity between the buprenorphine treated groups compared 
with the S controls at 30 min (Fig. 1; H = 10.036, d.f. = 4, P = 0.040), with all groups having similar activity 
levels to the S group except group 0.05BA (U = −1.984, P = 0.047) which had lower activity. By 180 min 
activity was similar in buprenorphine and S groups (H = 6.372, d.f. = 4, P = 0.173). However, at both 30 
min and 180 min activity was significantly lower in groups 0.05BA and 0.10BA compared with pre-
treatment levels (Fig. 1; W = 2.023, P = 0.043 at 30 and 180 min). Carprofen treated groups had similar 
activity values compared to S controls at 30 min (H = 6.609, d.f. = 4, P = 0.158) and at 180 min (H = 
3.729, d.f. = 4, P = 0.444). However, at 30 min activity was significantly lower than pre-treatment levels in 
groups 5.0CA and 5.0CS (Fig. 1; W = 2.023, P = 0.043), and in group 5.0CA the time spent active was 
still lower than pre-treatment levels at 180 min (W = 2.023, P = 0.043) showing a prolonged side-effect of 
this dose. Comparisons between the lidocaine treated groups and saline controls did not reveal any 
differences between the groups either at 30 (Fig. 1; H = 5.147, d.f. = 4, P = 0.273) or at 180 min (H = 
1.194, d.f. = 4, P = 0.879). However, at 30 min a significant reduction in activity was observed in group 
1.0LA in comparison with pre-treatment (W = 2.023, P = 0.043), but by 180 min activity in this group had 
recovered towards baseline activity. 
3.3. Analgesic effects on physiology 
3.3.1. Plasma cortisol 
There were no significant differences between the plasma cortisol concentrations in any of the 
buprenorphine treated groups (H = 5.258, d.f. = 5, P = 0.385), nor the carprofen treated groups (H = 
7.117, d.f. = 5, P = 0.212) compared with the saline and acid groups. However, there was a trend for 
plasma cortisol to be lower in the lidocaine groups, 1.0LA and 1.0LS (H = 11.039, d.f. = 5, P = 0.051).  
3.3.2. Ventilation rate 
At 30 min after treatment, all buprenorphine treated groups had higher ventilation rates than their 
pretreatment levels (Fig. 2B; W = 2.023, P = 0.043 for all groups). Ventilation rates differed between the 
groups at this time point (H = 15.303, d.f. = 4, P = 0.004); where most groups had higher ventilation rates 
than the S group (0.01BA U = −2.627, P = 0.009; 0.05BA U = −2.627, P = 0.009; 0.01BS U = −2.102, P = 
0.036) except group 0.1BA (U = −1.781, P = 0.075). By 180 min most groups had recovered, with only 
group 0.01BA having a significantly higher ventilation rate than pre-treatment (Fig. 2, P = 0.043). There 
was no difference in ventilation rate between the buprenorphine treated groups and S controls at 180 min 
(Fig. 2C; H = 6.375, d.f. = 4, P = 0.173).  
All carprofen treated groups also had higher ventilation rates at 30 min post-treatment compared to pre-
treatment (Fig. 2B; 1.0CA W = 2.032, P = 0.042; 2.5CA W = 2.023, P = 0.043; 5.0CA W = 2.032, P = 
0.042; 5.0CS W = 2.023, P = 0.043). Overall ventilation rate differed between the groups (H = 15.699, d.f. 
= 4, P = 0.003), where all carprofen treated groups had higher ventilation rates in comparison with the S 
group (1.0CA U = 2.619, P = 0.009; 2.5CA U = 2.627, P = 0.009; 5.0CA U = 2.619, P = 0.009; 5.0CS U = 
2.227, P = 0.026). By 180 min, rates in these groups recovered towards pre-treatment levels, and only the 
ventilation rate of group 5.0CS remained high (W = 2.023, P = 0.043). By this time point carprofen groups 
had similar ventilation rates to the S controls (Fig. 2C; H = 5.485, d.f. = 4, P = 0.241). 
Similarly, ventilation rate increased in all lidocaine treated groups at 30 min post-treatment in comparison 
with pre-treatment levels (Fig. 2B, 0.5LA U = 2.032, P = 0.042; 1.0LA U = 2.041, P = 0.041; 2.0LA U = 
2.023, P = 0.043; 1.0LS U = 4.785, P < 0.01). However, there was no difference in ventilation rate 
between the groups and saline at this time point (H = 4.453, d.f. = 4, P = 0.348). By 180 min, rates in all 
groups recovered towards pre-treatment levels except group 0.5LA (W = 2.023, P = 0.043). At 180 min  
there was no difference in ventilation rate between the groups (Fig. 2C; H = 5.657, d.f. = 4, P = 0.226). 
When considering the rate of recovery in ventilation rate between 30 and 180 min post-treatment, 
buprenorphine groups differed from the S group (Fig. 3; H = 13.543, d.f. = 4, P = 0.009). Recovery rates 
in groups 0.05BA (U = −2.514, P = 0.012) and 0.10BA (U = −1.984, P = 0.047) were higher than S fish, 
whereas fish in groups 0.01BA and group 0.01BS had similar rates (0.01BA, U = −1.257, P = 0.209; 
0.01BS, U = −0.524, P = 0.60; Figs. 2B and 3). Rate of recovery did not differ between the carprofen 
treated groups (Fig. 3; H = 8.588, d.f. = 4, P = 0.072), nor between lidocaine treated fish when compared 
with S controls (Fig. 3; H = 5.293, d.f. = 4, P = 0.259).  
 
Table 2. Chi-squared (𝑋2) analysis of the time to resume feeding. Contingency table showing the number of fish that 
resumed feeding at each time point after the treatment: saline (S); acid (A); buprenorphine and acid (dose/kg BA); 
buprenorphine and saline (BS); carprofen and acid (dose/kg CA); carprofen and saline (CS); lidocaine and acid 
(dose/fish LA) and lidocaine and saline (LS) as described in Table 1 (n = 5 for each group; NS = not significant, i.e. 
no skew towards early feeding). 
 Number of fish eating at time point (min) 
X2 value P value 
 30 60 90 120 150 180 
S 5 0 0 0 0 0 26.8 0.001 
A 3 1 0 1 0 0 9.99 NS 
0.01BA 1 3 0 0 0 1 9.99 NS 
0.05BA 3 0 1 0 0 1 9.99 NS 
.0BA 2 1 2 0 0 0 7.59 NS 
0.01BS 2 2 0 1 0 0 7.59 NS 
1.0CA 3 0 1 0 0 1 9.99 NS 
2.5CA 4 0 0 0 1 0 17.2 0.01 
5.0CA 5 0 0 0 0 0 26.8 0.001 
5.0 CS 4 1 0 0 0 0 17.2 0.01 
0.5LA 2 0 2 0 0 1 7.59 NS 
1.0LA 3 0 2 0 0 0 12.4 0.05 
2.0LA 4 1 0 0 0 0 17.2 0.01 
1.0LS 5 0 0 0 0 0 26.8 0.001 
Expected values 0.833 0.833 0.8773 0.833 0.833 0.833 --- --- 
 
Fig. 2. A. The median ventilation rate (opercular beat rate per min, OBR) of the saline and acid injected groups 
illustrating the baseline measurements (0 min), the highest rates at 30 min and recovery at 180 min (n = 5 per group). 
The median percentage (± IQR) change in ventilation rate from pre-treatment values at (B) 30 min and (C) 180 min 
after rainbow trout were injected with saline, acid, buprenorphine and acid (BA), carprofen and acid (CA), lidocaine 
and acid (LA) or one of the three analgesics and saline (BS, CS, LS). Dose of analgesic is given (mg kg−1 or per fish) 
next to the appropriate label (a = P < 0.05 compared with pre-treatment ventilation; b = P < 0.05 compared with 
saline; n = 5 per group). 
 
3.4. Comparison between the three analgesic drugs 
The doses considered most effective from the previous analysis (0.01BA, 5.0CA and 1.0LA) were 
compared with the S group to determine which of the drugs tested provided the most effective anti-
nociceptive or analgesic effect, such that it was no different from non-noxious stimulation. There was no 
difference in the time spent active between the three analgesic groups at 30 (H = 4.05, d.f. = 3, P = 0.256) 
and 180 min (H = 2.46, d.f. = 3, P = 0.482). At 30 min there was a significant difference in ventilation rate 
between the groups (H = 14.58, d.f. = 3, P = 0.002), with all treatment groups having higher ventilation 
rates than the S group except for the lidocaine treated group (0.01BA U = −2.63, P = 0.008; 5.0CA U =    
−2.619, P = 0.008; 1.0LA U = −0.105, P = 1.0). By 180 min the buprenorphine treated group still had 
higher ventilation rates than the S group (0.01BA U = −2.65, P = 0.008). In contrast, the carprofen and 
lidocaine groups were similar to the S group (5.0CA U = −1.89, P = 0.056; 1.0LA U = −1.37, P = 0.222). 
Nor was there a difference when comparing plasma cortisol concentration (H = 2.79, d.f. = 3, P = 0.424). 
4. Discussion 
Noxious treatment (injection of acid) resulted in increased ventilation rates and a reduction in time spent 
active compared to saline-injected controls. Acid treated fish (A) also took longer to resume feeding. 
These results are similar to those of previous studies and are suggestive of a complex behavioural 
response to the noxious stimulus (Sneddon, 2003a; Reilly et al., 2008a). Buprenorphine (B) treatment 
had limited effect on the fishes’ response to the noxious treatment. None of the doses reduced the 
suspension of feeding behaviour or the accompanying decrease in activity. Carprofen (C) appeared to 
have some analgesic or anti-nociceptive effect, as treatment with both 2.5 mg kg−1 and 5.0 mg kg−1 
reduced the suspension in feeding behaviour. However, C treatment did not have any beneficial effect on 
activity; indeed, fish in both the acid treated (CA) and saline (CS) treated 5.0 mg kg−1 carprofen groups 
spent less time active than fish in the acid alone group, possibly indicating an unwanted side effect of C. 
In addition, C treated groups had higher ventilation rates than fish in the S control group. The higher 
doses of lidocaine (L) appeared to act as an analgesic or anti-nociceptive since fish treated with both 1.0 
mg and 2.0 mg of L had similar ventilation rates, activity and resumed feeding at comparable times to the 
S control group. In comparisons between the analgesics, the 1.0 mg dose of L was the only drug to show 
significant benefit for all of the parameters measured. Therefore, this dose of lidocaine was deemed the 
most effective of the drugs tested. 
4.1. Effects of acid 
Previous studies in rainbow trout found that increased ventilation rate immediately following noxious 
stimulation was one of the most marked effects of noxious stimulation (Sneddon, 2003a; Sneddon et al., 
2003; Reilly et al., 2008a; Ashley et al., 2009; Newby et al., 2009). The present result confirms this, 
suggesting that ventilation rate is a useful indicator of nociception or pain perception in the rainbow trout. 
Reduced activity in response to a noxious stimulus has been recorded in Koi carp, zebrafish (Danio rerio) 
and trout (Harms et al., 2005; Reilly et al., 2008a; Ashley et al., 2009) as well as in non-fish species 
(Gentle and Hill, 1987; Roughan and Flecknell, 2000; Underwood, 2002; Walker et al., 2009). Such 
reductions in activity could be viewed as a protective, vegetative response to prevent further injury and 
aid recovery. However, changes in activity level suggest a complex behavior rather than a reflex reaction 
(Gentle and Hill, 1987), indicating higher brain processing that may control decision making. In the 
present study, feeding was suspended following acid administration. Reduced appetite can be a clinical 
sign of pain (Bateson, 1991; Mayer, 2007), and increased latency to feeding has been found in previous 
studies assessing the effects of acetic acid on trout behaviour (Sneddon, 2003a; Sneddon et al., 2003).  
Plasma cortisol concentrations were not elevated by noxious treatment, as previously reported by Ashley 
et al. (2009) in rainbow trout. Considerable individual variation was seen in plasma cortisol within all 
groups. Studies have shown that cortisol concentrations in fish vary, and are dependent upon individual 
status such as stress coping style where divergent stress responses have been recorded (Overli et al., 
1999; Thomson et al., 2011). Therefore, differences may not have been observed here owing to the 
relatively low sample sizes, which were chosen based on ethical considerations. However, none of the 
analgesics resulted in higher plasma cortisol, suggesting that they may not cause a physiological stress 
response.  
 
Fig. 3. The median (±IQR) rate of recovery in opercular beat rate over the experimental period (30–180 min) after 
rainbow trout were injected with saline, acid, buprenorphine and acid (BA), carprofen and acid (CA), lidocaine and 
acid (LA) or one of the three analgesics and saline (BS, CS, LS). Dose of analgesic is given (mg kg−1 or per fish) next 
to the appropriate label (a = P < 0.05 compared with saline; n = 5 per group). 
 
4.2. Buprenorphine 
Overall, buprenorphine (B) treatment showed minimal analgesic or anti-nociceptive actions. The only 
dose to have a positive effect on ventilation rate was 0.1 mg kg−1; fish in this group demonstrated a lower 
ventilation rate at 30 min after treatment. The fact that ventilation rates were not generally lower in B 
treated fish could be considered surprising as opioids tend to induce respiratory depression in humans, 
even at therapeutic doses (Rang et al., 2007). However, B is thought to produce less respiratory 
depression than other opioids (Papich, 2007) and in non-primates therapeutic doses of opioids do not 
cause marked respiratory depression (Grant, 2006; Wagner, 2009). Newby et al. (2007) found that 
administration of a high dose of morphine did not alter respiratory rate in winter flounder 
(Pseudopleuronectes americanus) and Sneddon (2003a) reported that administration of morphine did not 
affect the respiratory rate of trout. Thus, it is possible that opiates do not cause respiratory depression in 
fish. The impact of such drugs on ventilation rate and its usefulness as an indicator of analgesic effect 
need further investigation. 
All B groups, including the saline control group, took significantly longer to resume feeding than the saline 
alone control group, suggesting that not only did the drug not have an anti-nociceptive or analgesic effect, 
but that in itself it produced adverse effects. Decreased appetence may occur as a general response to 
stress (Bernier, 2006), but opioids are also known to directly cause gastrointestinal side-effects (Grant, 
2006; Wagner, 2009). However, Sneddon’s (2003a) study found that fish treated with morphine resumed 
feeding as rapidly as control fish, and in the study by Harms et al. (2005) another opioid, butorphanol, had 
no apparent adverse effects on feeding, indicating that gastrointestinal side effects of opioids might not be 
an issue in fish. The possibility that buprenorphine use might inhibit feeding could be a factor to consider 
if this drug was ever used in circumstances where rapid resumption of feeding in experimental studies 
was required. The discrepancy in disruption to feeding caused by these drugs and findings from fish 
studies should be explored particularly in using latency to feed as an indicator of the efficacy of 
analgesics.  
The higher doses of B reduced activity, even when administered alone. Buprenorphine can have a 
sedative action in mammals (Glennon and Jeffs, 2001; Rang et al., 2007) and it may be that at higher 
doses the behavior of the fish was influenced by sedation so that activity was reduced. If this was the 
case then it would appear that the effects of the lowest dose were diminished by the end of the 
experimental time period whereas the higher doses of buprenorphine still reduced activity after 180 min. 
Again this detrimental impact upon activity may be an undesirable side-effect in behavioural studies. 
4.3. Carprofen 
Treatment with the two higher doses of carprofen (C) had a beneficial effect on the time taken to resume 
feeding, suggesting anti-nociceptive or analgesic properties in the trout. NSAIDs exert their effects 
through inhibition of arachidonate cyclo-oxygenase (COX) enzymes to reduce inflammation and depress 
afferent pain fibre transmission. COX enzymes have been identified in a teleost (Grosser et al., 2002; 
Teraoka et al., 2009), and a study by Harms et al. (2005) demonstrated a beneficial effect of ketoprofen 
on reducing inflammation in carp; therefore, C was expected to have some efficacy in fish. 
When C was administered in combination with saline (CS), fish demonstrated higher ventilation rates than 
when given saline alone (S), possibly reflecting a stress response elicited by C. This drug did not 
ameliorate changes in activity induced by acetic acid (A), and carprofen alone (CS) at 5.0 mg kg−1 
resulted in a decrease in activity. This effect on activity was not seen at 2.5 mg kg−1, so although the 5.0 
mg kg−1 dose was used in the control study the 2.5 mg kg−1 dose demonstrated the more beneficial effect 
overall.  
It is possible that the doses used in the present experiment were not high enough to provide complete 
anti-nociception or analgesia. They were chosen based on those routinely used in mammalian veterinary 
practice but a study on C analgesia in chickens exposed to an acute noxious stimulus found that 
observable behavioural effects only occurred above 30 mg kg−1 (Hocking et al., 2005). However, studies 
on the effects of C on chronically lame chickens found doses of 1 mg kg−1 and 4 mg kg−1 to be effective 
(McGeown et al., 1999; Danbury et al., 2000). Nonetheless, there are significant species differences in 
the pharmacokinetics of NSAIDs (Hocking et al., 2005; Grant, 2006), and assessment of the 
pharmacokinetics of carprofen (and other NSAIDs) could be helpful in the determination of suitable 
dosing regimes for fish. 
Carprofen treatment did not affect cortisol concentrations, but the apparent negative effect of the highest 
dose on activity does suggest that further testing is advisable. Adverse side effects of NSAIDs in species 
other than fish tend to be more of an issue with their long term use rather than in acute treatment (Grant, 
2006; Budsberg, 2009). The two higher doses (2.5 and 5.0 mg kg−1) were the most effective, but the 5.0 
mg kg−1 dose adversely affected activity. Further work is needed to determine all the possible factors 




The two higher doses of lidocaine (L) had a positive effect on all of the indicators measured. Although the 
2 mg dose appeared to have the more beneficial effect on cortisol concentrations, administration of 1 mg 
was deemed most effective as fish given this dose exhibited faster physiological and behavioural 
recovery. Local anaesthetics are usually administered to a specific area, but ultimately they are absorbed 
systemically. Cortisol levels were unaffected by L treatment alone (LS) compared with S controls; 
therefore, it does not appear to induce a stress response in trout under these experimental conditions. As 
no side effects were observed it would indicate that the higher doses tested were within the therapeutic 
range of the drug. Therefore, L can be recommended as an effective anti-nociceptive or analgesic in trout 
exposed to an acute noxious stimulus with the 1.0 mg dose of L the most effective of the three doses 
tested. 
Based on parameters measured in this study, comparisons between the different analgesics revealed that 
L was the most effective of the three drugs. Local anaesthetics are used in mammals to provide localized 
analgesia, and so the effectiveness of lidocaine in alleviating responses to localised acid stimulus enables 
direct comparisons with this drug’s use in higher vertebrates (Grant, 2006; Ashley, 2007; Rang et al., 
2007; Mama, 2009). Although L has been studied as an anaesthetic (Carrasco et al., 1984; Park et al., 
2009), this is the first study to assess its use as an analgesic agent in fish. Further testing and validation 
is needed since there may be species differences in the behavioural and physiological response to 
lidocaine. These studies should employ pharmacokinetics to precisely understand drug dynamics linked 
to their behavioural and physiological effects. 
5. Conclusions 
This study compared a range of analgesic drugs at various doses in a single teleost fish species under 
the same experimental conditions. Ventilation rate, feeding and activity were all adversely affected by 
noxious, potentially painful stimulation. Our results demonstrate that ventilation rate and latency to 
resume feeding could both be used to assess the response to injurious stimuli in trout, and possibly other 
teleost fish.  
All three drugs demonstrated some beneficial effects in noxiously treated fish. However, lidocaine 
administered at 1.0 mg per fish produced no side effects and was the most effective at alleviating adverse 
responses to the acetic acid administration. The choice of lidocaine as an analgesic agent would be 
practical for use during routine procedures such as tagging. Further research on topical lidocaine spray or 
cream could also prove beneficial: for example, in the removal of hooks during catch-and-release angling 
(Tennant, 2005). It is possible that both buprenorphine and carprofen may be of use in different 
circumstances, when injuries are of a more chronic nature: for example, following surgery or as part of the 
treatment protocol in disease conditions that might be considered to cause pain in valuable ornamental 
species. However, these drugs were not particularly effective in the acute pain tests in the present study 
and resulted in unwanted side-effects which may confound experimental studies. 
Further work is necessary to reliably assess the efficacy of analgesic drugs on a variety of fish species as 
studies have shown species specific behavioural responses to noxious stimuli (Reilly et al., 2008a) and 
different responses to analgesics including pharmacokinetics (Davis et al., 2006; Newby et al., 2006). 
Research targeting species that are subject to invasive laboratory experiments would be the first step in 
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